Literature DB >> 18021514

Quality measures in osteoarthritis.

M C Hochberg1.   

Abstract

Published guidelines emphasize a multidisciplinary approach to management of patients with osteoarthritis (OA), yet studies have demonstrated substantial variation in the treatment approach of both primary care physicians and rheumatologists. During the past decade, quality indicators have been developed by several groups in order to provide a minimally acceptable standard of care. This article summarizes the results of a qualitative systematic review of the English-language literature on quality indicators for osteoarthritis and highlights relevant indicators published by the Arthritis Foundation and American College of Rheumatology.

Entities:  

Mesh:

Year:  2007        PMID: 18021514

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  Quality indicators for knee and hip osteoarthritis care: a systematic review.

Authors:  Ilgin G Arslan; Rianne M Rozendaal; Marienke van Middelkoop; Saskia A G Stitzinger; Maarten-Paul Van de Kerkhove; Vincent M I Voorbrood; Patrick J E Bindels; Sita M A Bierma-Zeinstra; Dieuwke Schiphof
Journal:  RMD Open       Date:  2021-05

2.  Quality of hip and knee osteoarthritis management in primary health care in a Norwegian county: a cross-sectional survey.

Authors:  Gudmund Grønhaug; Nina Østerås; Kåre Birger Hagen
Journal:  BMC Health Serv Res       Date:  2014-11-25       Impact factor: 2.655

3.  Self-reported quality care for knee osteoarthritis: comparisons across Denmark, Norway, Portugal and the UK.

Authors:  N Østerås; K P Jordan; B Clausen; C Cordeiro; K Dziedzic; J Edwards; G Grønhaug; A Higginbottom; H Lund; G Pacheco; S Pais; K B Hagen
Journal:  RMD Open       Date:  2015-10-20

Review 4.  Quality indicators for the primary care of osteoarthritis: a systematic review.

Authors:  J J Edwards; M Khanna; K P Jordan; J L Jordan; J Bedson; K S Dziedzic
Journal:  Ann Rheum Dis       Date:  2013-11-27       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.